Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 15, 2007

View Archived Issues

AstraZeneca reviews development and regulatory advances of fourth quarter

Novel tubulin polymerization inhibitors identified at Threshold Pharmaceuticals

CNTO-1275 effective in phase II psoriasis trial

Lacosamide significantly reduces pain in peripheral diabetic neuropathy

New treatment option for urological disorders disclosed in recent Ranbaxy patent

Novel anticancer agents imparted in recent Novartis patent

Recent patents describe new therapeutic agents for neurological disorders

Recent patents describe novel analgesic agents

Long-acting octreotide to be investigated in polycystic liver disease

FG-4539 neuroprotective in stroke model

Studies support phase III investigations of ancrod in stroke

Kadian pharmacokinetics not significantly affected by alcohol

Forbes Medi-Tech restructures

Avanex announces preclinical oncology compounds

R-763 studied in phase I for hematological malignancies

Phase III clinical trial under way for LymphoStat-B in SLE

Poniard seeks to begin clinical testing of oral picoplatin

Elixir and Siena Biotech collaborate on SIRT1 inhibitors in Huntington's disease

BL-1020 successfully completes phase I trials for schizophrenia

Seattle Genetics awarded orphan drug designations for SGN-33 and SGN-35

GW and Otsuka establish strategic cannabinoid alliance

Hemospan studied in parallel European phase III trials

TG-4040 studied in phase I trial for chronic HCV

Silenor NDA filing on track for Q3 2007

ThromboView phase II DVT results confirm efficacy

DDP-733 produces statistically significant clinical response rate in IBS-c

AzaSite Plus well tolerated in phase I study

Replagal launching in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...